Agoracom: Small Cap Investment - Zenith Epigenetics - Targeting bromodomain and extraterminal proteins in breast cancer

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Targeting bromodomain and extraterminal proteins in breast cancer

posted on Nov 27, 2017 12:41PM

Targeting bromodomain and extraterminal proteins in breast cancer

https://www.ncbi.nlm.nih.gov/pubmed/29154989

http://www.sciencedirect.com/science/article/pii/S1043661817314032?via%3Dihub

3 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply